Munch-a-Biotech Today Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (785)	12/31/1999 12:10:00 PM
From: Jim H	Read Replies (2) of 3158

Peter, thanks for all your excellent contributions to the SI biotech boards. Wish I could contribute more, but I lack the expertise. Don't believe that I have seen anyone mention ERGO Science Corp (ERGO) on this board. Sells for about half of its cash on hand. No lawsuits that I can see. Currently working with FDA regarding safety issues on its diabetes drug. Slow burn rate. biz.yahoo.com An acquirer could pay double the current market price for the shares, get enough cash in the company to fund the entire purchase, and get drug candidate and research base for nothing. Of course a friendly takeover would be required since insiders own most of the shares. Any comments? JimH

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next